Phoenix Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 M
- Satisfied Charges ₹ 4.83 M
- Revenue Growth 17.51%
- Profit Growth 24.16%
- Ebitda 27.37%
- Net Worth 35.53%
- Total Assets 17.42%
About Phoenix Bio Sciences
Phoenix Bio Sciences Private Limited (PBSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 March 2011 and has a history of 13 years and 11 months. Its registered office is in Vellore, Tamil Nadu, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹5.50 M. The company has closed loans amounting to ₹4.83 M, as per Ministry of Corporate Affairs (MCA) records.
Pondichery Mohankumar, Mohan Sundari, Raja Singla, and One other member serve as directors at the Company.
Company Details
- Location
Vellore, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74990TN2011PTC079806
- Company No.
079806
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Phoenix Bio Sciences Private Limited offer?
Phoenix Bio Sciences Private Limited offers a wide range of products and services, including Bakery & Confectionery Products, Confectionery Ingredients, Flavours & Aromatics, Food Stabilizer, HDPE Bags, HDPE Woven Bags, Chemical Plants & Machinery, Soap Making Machinery.
Who are the key members and board of directors at Phoenix Bio Sciences?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pondichery Mohankumar ![]() | Managing Director | 23-Mar-2011 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Raja Singla ![]() | Director | 25-Apr-2012 | Current |
Mohan Sundari ![]() | Director | 23-Mar-2011 | Current |
Shivom Singla ![]() | Director | 25-Apr-2012 | Current |
Financial Performance of Phoenix Bio Sciences.
Phoenix Bio Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.51% increase. The company also saw a substantial improvement in profitability, with a 24.16% increase in profit. The company's net worth Soared by an impressive increase of 35.53%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Phoenix Bio Sciences?
Unlock access to Phoenix Bio Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹5.50 M
₹4.83 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.55 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
22 Jun 2011 | Canara Bank | ₹5.50 M | Open |
06 Sep 2019 | Canara Bank | ₹1.90 M | Satisfied |
14 Nov 2018 | Canara Bank | ₹0.60 M | Satisfied |
14 Nov 2018 | Canara Bank | ₹1.00 M | Satisfied |
15 Oct 2012 | Canara Bank | ₹0.53 M | Satisfied |
How Many Employees Work at Phoenix Bio Sciences?
Unlock and access historical data on people associated with Phoenix Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Phoenix Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phoenix Bio Sciences's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.